Group One Trading
BLRX

Group One Trading’s BioLineRX BLRX Stock Holding History

Group One Trading’s Portfolio BLRX Stock Details BLRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-79
Closed -$292 – 7948
2025
Q1 		$234 Buy
+79
New +$318 ﹤0.01% 7363
2024
Q2 		– Sell
-80
Closed -$2.15K – 6737
2024
Q1 		$3.57K Buy
+80
New +$4.01K ﹤0.01% 6319
2023
Q3 		– Sell
-77
Closed -$5.17K – 7656
2023
Q2 		$4.92K Hold
77
– – ﹤0.01% 6719
2023
Q1 		$2.71K Hold
77
– – ﹤0.01% 6532
2022
Q4 		$1.82K Sell
77
-164
-68% -$4.88K ﹤0.01% 6681
2022
Q3 		$9K Hold
241
– – ﹤0.01% 6544
2022
Q2 		$12K Sell
241
-7
-3% -$389 ﹤0.01% 6641
2022
Q1 		$17K Sell
248
-23
-8% -$1.6K ﹤0.01% 6854
2021
Q4 		$22K Buy
271
+161
+146% +$16.8K ﹤0.01% 6908
2021
Q3 		$12K Buy
+110
New +$13.1K ﹤0.01% 7414

Other funds holding BLRX

XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $133B AUM 43.5% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
NRG
Nemes Rush Group Novi, Michigan $1.05B AUM 30.08% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $33.6B AUM 31.03% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Group One Trading's BLRX Position: Q2 2025 in Review

Group One Trading sold out of BioLineRX (BLRX) in Q2 2025, closing a stake of 79 shares — an estimated $292 sold.

Group One Trading first reported a position in BLRX in Q3 2021 and held it in 10 quarters. The position peaked at $22K in Q4 2021. 17 funds tracked by Wall St. Rank hold BLRX as of Q2 2025.

  • Group One Trading reported no remaining BioLineRX position as of Q2 2025 after selling out during the quarter.
  • Group One Trading sold 79 BioLineRX shares in Q2 2025, an estimated $292.
  • Group One Trading first reported a position in BioLineRX in Q3 2021 and held it in 10 quarters.
  • Group One Trading's BioLineRX position peaked at $22K in Q4 2021.
  • 17 funds tracked by Wall St. Rank held BioLineRX as of Q2 2025.

Based on Group One Trading's 13F filing for Q2 2025, filed 14 Aug 2025.